Mass fragmentographic determination of 4-amino-3-p-chlorophenylbutyric acid (baclofen) in cerebrospinal fluid and serum
- 1 March 1979
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 162 (3) , 433-438
- https://doi.org/10.1016/s0378-4347(00)81532-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Synthesis of 4-amino-3-p-chlorophenyl-butyric acid-2, 2, 4, 4-2H4 (baclofen)Journal of Labelled Compounds and Radiopharmaceuticals, 1978
- Baclofen treatment in chronic schizophrenia: a clinical trialAmerican Journal of Psychiatry, 1977
- A double‐blind trial of baclofen against placebo in the treatment of schizophreniaActa Psychiatrica Scandinavica, 1976
- BACLOFEN IN SCHIZOPHRENIAThe Lancet, 1976
- BACLOFEN IN SCHIZOPHRENIAThe Lancet, 1976
- The determination of γ-amino-β-(p-chlorophenyl)butyric acid (baclofen) in biological material by gas-liquid chromatographyJournal of Chromatography A, 1976
- Antagonism between Lioresal and substance P in rat spinal cordBrain Research, 1975
- BACLOFEN IN THE TREATMENT OF SCHIZOPHRENIAThe Lancet, 1975
- Plasma and cerebrospinal fluid levels of baclofen (lioresal®) at optimal therapeutic responses in spastic paresisJournal of the Neurological Sciences, 1974
- A new agent for the control of spasticityJournal of Neurology, Neurosurgery & Psychiatry, 1970